Trademarkia Logo

Canada

C$
GVOKE VIALDX
FORMALIZED

on 10 Apr 2024

Last Applicant/ Owned by

Xeris Pharmaceuticals, Inc.

180 N LaSalle Street, Suite 1810Chicago IL 60601

US

Serial Number

2320951 filed on 9th Feb 2024

Correspondent Address

NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L.,S.R.L.

3700 CANTERRA TOWER400 - THIRD AVENUE S.W.CALGARY

ALBERTA

CA

T2P4H2

GVOKE VIALDX

Trademark usage description

pharmaceutical preparations for in vivo diagnostic use; pharmaceutical preparations for diagnostic radiology use. providing information relating to d Read More

Classification Information


Class [005]
Pharmaceutical preparations for in vivo diagnostic use; pharmaceutical preparations for diagnostic radiology use.


Classification kind code

12

Class [044]
Providing information relating to diagnostic properties of pharmaceuticals.


Classification kind code

12

Mark Details


Serial Number

2320951

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 256
on 11th Feb 2025
Notification of Possible Opposition Sent
Submitted for opposition 48
on 29th Apr 2024
Agent Changed
Submitted for opposition 257
on 11th Apr 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 10th Apr 2024
Created
Submitted for opposition 31
on 10th Apr 2024
Formalized
Submitted for opposition 228
on 9th Feb 2024
International Registration
Submitted for opposition 30
on 9th Feb 2024
Filed